• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Modified hepatitis B vaccination regimen in HIV-infected patients associated with improved immune response

byJames EnglandandAnees Daud
April 12, 2016
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In HIV-infected individuals, a modified hepatitis B vaccination regimen which consisted of a higher dose compared to the standard regimen led to an increased proportion of patients with positive titers and a greater duration of response.

2. Predictors of positive long-term vaccination response included high level initial response, greater time since HIV diagnosis, lower HIV RNA level, CD4 count >350/mL, and non-smoking status.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Individuals infected with HIV often carry risk factors for hepatitis B virus (HBV) infection, and are recommended to undergo vaccination. These patients have a poorer serologic response to immunization compared to the general population. The described study sought to evaluate the long-term immune titer response in HIV-infected patients following standard intramuscular three doses of 20 mg (IM20 x3) compared to two alternate regimens. The alternate regimens were intramuscular four doses of 40 mg (IM40 x4) and intradermal four doses of 4mg (ID4 x4).

The increased antigen exposure with the IM40 x4 regimen led to an increased proportion of patients with positive titers at 42 months of follow up compared to the other two groups. The duration of response was also greater in the IM40 x4 group. This trial had a good sample size and study design, so the results are applicable to HIV-infected population. However, there was a high loss of follow-up rate of 28.6% by the end of the study period. While the alternative vaccine regimen seemed to improve serologic markers of immunity, the clinical relevance in terms of rates of infection may not be clinically reduced in the higher antigen-exposure group.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

Second-line TAF-based ART improves viral suppression in pediatric HIV

Alcohol use disorder may be associated with human immunodeficiency virus

Relevant Reading: Long-term response rates of successful hepatitis B vaccination in HIV-infected patients

In-Depth [randomized controlled trial]: This phase 3 open-label multicenter trial included 437 patients with HIV-1 infection, CD4 count >200/uL and seronegative for HBV infection. Patients were randomized to standard immunization with three doses (20 mg) of intramuscular recombinant HBV vaccine (IM20 x3), or alternative regimens with four doses of 40 mg of vaccine intramuscularly (IM40 x4), or 4 intradermal injections of 4mg (ID4 x4).

The proportion of patients with serologic response at 42 months was 41% (95%CI 33-49%) for the control regimen, 71% (95%CI 64-79%) for the IM40 x4 group, and 44% (95%CI 35-53%) for the ID4 x4 group. In multivariate analysis, sustained response at 18 months was associated with the IM40 x 4 regime (OR 3.54; 95%CI 1.59-7.86), CD4 count >350/uL (OR 2.26; 95%CI 1.13-4.51), longer time since HIV diagnosis (OR per year 1.06; 95%CI 1.01-1.12), and high initial response at 28 weeks (OR 25.8; 95%CI 11.3-59.0). Lower response was associated with active smoking (OR 0.41; 95%CI 0.23-0.74). Duration of response was greater in the IM40 x4 group with time to loss of positive titer in 15% of patients at 33.1 months, compared to 8.7 months and 6.8 months in the standard, and ID4 x4 groups, respectively.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hepatitis bHIVhuman immunodeficiency virus (HIV)
Previous Post

Magnetic resonance imaging associated with higher rate of repeat ambulatory examinations

Next Post

Quality improvement interventions not associated with decreased mortality in Brazilian ICUs

RelatedReports

Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

June 16, 2025
Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Alcohol use disorder may be associated with human immunodeficiency virus

May 3, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
Next Post
Corticosteroids improve outcomes in treatment of community-acquired pneumonia

Quality improvement interventions not associated with decreased mortality in Brazilian ICUs

Medical home linked to lower pediatric readmission rate

Decreased air pollution associated with fewer episodes of childhood bronchitis

HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Transitional care intervention program may reduce high-risk readmissions

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.